Study observing medicine being prescribed to patients with Psoriasis at SMS hospital, Jaipur

Not yet recruiting

• Conditions: Psoriasis,

• Registration Number: CTRI/2025/03/083598
• Lead Sponsor: Dr. Dinesh Kumar

Brief Summary

Psoriasis is a chronic, inflammatory skin condition marked by red, scaly plaques, typically on the scalp, elbows, and knees, though it can affect other areas like the hands, feet, and trunk. It involves a combination of genetic predisposition and environmental triggers such as trauma, stress, or medications, and can lead to systemic issues in various organs. The disease is characterized by epidermal hyperproliferation, inflammatory infiltration, and abnormal angiogenesis. Symptoms commonly include itching, irritation, and pain, and psoriasis significantly impacts quality of life. Various forms of psoriasis exist, including plaque, guttate, pustular, and erythrodermic types.



Treatment varies based on disease severity, with mild psoriasis managed by topical treatments like corticosteroids, emollients, and vitamin D3 analogues. More severe cases require systemic therapies or phototherapy. Evaluating prescribing patterns is essential for ensuring rational drug use, as inappropriate prescribing can lead to ineffective treatment, increased costs, and adverse effects. Adherence to prescribed medication is crucial for successful treatment, and patient preferences, treatment efficacy, and comorbidities influence medication choices. Monitoring and optimizing drug use can help minimize side effects and improve treatment outcomes.

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2025-03-26
• Study Start: 2025-10-04

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• Patients attending OPD of dermatology diagnosed with psoriasis.
• 2.Patients diagnosed with psoriasis with comorbidities.
• 3.Old and newly diagnosed patients 4.Patients who agreed to sign the informed consent form.

Exclusion Criteria

• Pregnant and lactating patients.
• Inpatient department patients.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. Proportion of cases where drugs were prescribed according to STGs.	At baseline
2.Average number of drugs per encounter.	At baseline
3.Percentage of drugs prescribed with the generic name.	At baseline
4.Percentage of encounters with antibiotics prescribed.	At baseline
5.Percentage of encounters with injections prescribed.	At baseline
6.Percentage of drugs prescribed from Essential Drugs List (EDL).	At baseline

Secondary Outcome Measures

Name	Time	Method
1. To assess the health-related quality of life of diagnosed cases via DLQI scale.	2.To estimate the sociodemographic & clinical profile among recruited patients.

Trial Locations

Locations (1)

Sawai Man Singh Hospital; 🇮🇳 Jaipur, RAJASTHAN, India

Sawai Man Singh Hospital

🇮🇳Jaipur, RAJASTHAN, India

Dr Dinesh Kumar

Principal investigator

9887759136

dineshsharma.ds09@gmail.com